Follikuláris limfóma: vizsgálatok itt: Dánia
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Randomized, placebo-controlled, double-blinded Phase 2 Trial of Dapagliflozin for Preventing Treatment-associated Cardiotoxicity in Lymphoma
- Where
- Aalborg, Aarhus N, Herning, Koege, Odense C, Vejle
- Életkor
- 18 év and over
- People
- 74
- Run by
- Aalborg University Hospital
See details and how to join2025-521205-41-00 · EU 2025-521205-41-00 - 1. fázisTaking peopleA Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Where
- Aarhus, Copenhagen
- Életkor
- 18 év and over
- People
- 215 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07101328 · EU 2025-524180-20-00 - 3. fázisTaking peopleA Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Where
- Aalborg, Copenhagen Oe, Odense, Roskilde
- Életkor
- 18 év to 130 év
- People
- 1018 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06549595 · EU 2023-510098-33-01 - 2. fázisTaking peopleSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Where
- Copenhagen Oe, Vejle
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00 - 1/2. fázisTaking peopleA Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Where
- København Ø
- Életkor
- 18 év and over
- People
- 174 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06542250 - 3. fázisNot yet taking people in DániaZoledronic acid as prophylaxis against glucocorticoid-induced osteoporosis in lymphoma
- Where
- Aalborg, Aarhus N, Copenhagen Oe, Herning, Odense C, Roskilde, Vejle
- Életkor
- 18 év and over
- People
- 132
- Run by
- Region Nordjylland
See details and how to join2026-527220-27-00 · EU 2026-527220-27-00 - 2. fázisTaking peoplePrimary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and rituximab-lenalidomide with a 1:1 randomization to tafasitamab for low-risk disease: a phase II study – NLG-FL7
- Where
- Aalborg, Aarhus N, Copenhagen Oe, Odense C, Roskilde
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Karolinska University Hospital
See details and how to join2023-508196-36-00 · EU 2023-508196-36-00